Business Insight's Key Players in Pharma Contract Manufacturing
Market developments, outsourcing hotspots and growth strategies
- Your Price: $3,835.00
- Add to Cart
Product Description:
The pharma contract manufacturing (PCM) industry continues to grow at a steady pace, driven by cost pressures, stringent regulatory requirements and patent expiries.
The highly competitive nature of the industry has been driving consolidation and companies are increasingly offshoring to emerging markets to reduce costs. As a result, players in key outsourcing destinations have been improving their manufacturing infrastructure to increasing their global competitiveness.
Business Insights' special report Key Players in Pharma Contract Manufacturing: Market developments, outsourcing hotspots and growth strategies examines the competitive landscape of the global PCM industry. The latest key issues and developments in the contract manufacturing market are identified and leading companies in this sector are profiled in detail.
For each of the top 10 contract CMO companies, this report provides a detailed examination of financial performance by business segment, manufacturing and R&D capacity, growth strategies and key acquisitions/divestments. This report also examines the size and growth of the global CMO industry, with analysis of major market drivers and trends in CMO destinations.
Understand the key developments, CMO location trends and business strategies of leading players in the contract manufacturing market
Click here to view the eight-page summary/table of contents of this report.
Key Players in Pharma Contract Manufacturing will help you :
- Compare the performances of the top 10 CMO companies across key business segments with this report's analysis of Catalent, Lonza, Boehringer Ingelheim (BI), DSM, Patheon, Evonik, Piramal, Jubilant, Aenova, Fareva.
- Identify the market dynamics of the global PCM industry over the 2003-07 period, discover which emerging markets are becoming the CMO destinations of the future and understand the major issues affecting key industry players.
- Assess the future prospects of the top 10 CMO companies with this report’s analysis of each firm’s manufacturing and R&D capability, growth strategies and M&A activity.
- Measure the progress of other leading CMO companies by evaluating the financial performances of Nipro, Siegfried, Haupt, Divi's Laboratories (Divi's), Cambrex, Recipharm, Archimica, Vetter, Famar and NextPharma.
The report will be delivered as a PDF via e-mail. Orders must be paid in full before shipment. All sales are final; no returns or refunds are permitted with this product. For more information, please call 877/464-2776 or e-mail account manager Maureen Croce at mcroce@hcpro.com.
Product Types : Departments :
SOURCE CODE: ESEARCHGOO
